Francis A. Farraye MD
Adjunct Professor, Gastroenterology
85 E. Concord St | (617) 638-8339
Center for Regenerative Medicine
Evans Center for Interdisciplinary Biomedical Research
Dr. Farraye is a Senior Associate Consultant in the Section of Gastroenterology and Hepatology at the Mayo Clinic in Jacksonville Florida where he co-directs the Inflammatory Bowel Disease Center. Prior to relocating in 2019, he was Clinical Director in the Section of Gastroenterology and the Inflammatory Bowel Disease Center at Boston Medical Center. At Boston University School of Medicine, he was Professor of Medicine. Dr. Farraye earned his medical doctorate from the Albert Einstein College of Medicine in New York and his master's degree in Epidemiology from the Harvard School of Public Health.
Dr. Farraye's clinical interests are in the care of patients with inflammatory bowel disease. He is currently investigating C. difficile infection in IBD patients, the management and diagnosis of dysplasia and cancer in patients with IBD; social media use and health literacy in IBD patients; hepatitis B vaccination efficacy in patients with IBD; and subclinical hepatic fibrosis in patients with IBD.
A frequent speaker and invited lecturer on topics on the diagnosis and management of inflammatory bowel disease, Dr. Farraye has authored or co-authored over 450 original scientific manuscripts, book chapters, reviews, and abstracts. He is the series editor for the text Curbside Consultations in Gastroenterology and co-edited the text, Curbside Consultation in Inflammatory Bowel Disease and Gastrointestinal Emergencies. His books for patients include Questions and Answers about Ulcerative Colitis, Questions and Answers about Crohn's Disease and Ulcerative Colitis for Dummies.
Dr. Farraye is a Fellow of the American Society of Gastrointestinal Endoscopy, American Gastroenterological Association and the American College of Gastroenterology. He has served on numerous national and international committees including as a member of the ACG Board of Trustees. He is co-chair of the Crohn's and Colitis Foundation Membership Committee and a member of the Chapter Medical Advisory Committee for the New England Crohn's and Colitis Foundation and a past chairman. The New England Crohn's and Colitis Foundation named Dr. Farraye Humanitarian of the Year in 2003. In 2009, the ACG awarded Dr. Farraye the William Carey Award for service to the college. Dr. Farraye has been recognized as "Top Doctor" in Gastroenterology by Boston Magazine and U.S. News and World Report since 2010.
MD, Albert Einstein College of Medicine, 1982
Epidemiology, MSc, Harvard School of Public Health, 2001
BS, Stony Brook University, 1978
Bhat S, Qazi T, Farraye FA. Managing infliximab infusions after a drug holiday. Am J Health Syst Pharm. 2021 09 07; 78(18):1664-1665. PMID: 34059875.Published on 9/4/2021
Bhat S, Caldera F, Farraye FA. Standardizing shared vaccination responsibilities among specialists to improve vaccination rates of immunosuppressed patients. Vaccine. 2021 Oct 01; 39(41):6015-6016. PMID: 34493411.Published on 9/1/2021
Shen B, Bortlik M, Bruining DH, Coelho-Prabhu N, El-Hachem S, Farraye FA, Iacucci M, Kobayashi T, Kochhar GS, Kotze PG, Lama YG, Levy AN, Liu X, Mao R, Navaneethan U, Schwartz DA, Shergill A, Sood A, Suárez BG. Endoscopic evaluation after surgery in inflammatory bowel disease - Authors' reply. Lancet Gastroenterol Hepatol. 2021 09; 6(9):691-692. PMID: 34391522.Published on 9/1/2021
Nigam GB, Patel RN, Bressler B, Hayee B, Iacucci M, Farraye FA, Limdi JK. Clinician perspectives on the use of artificial intelligence in inflammatory bowel disease. Gastrointest Endosc. 2021 09; 94(3):662-663. PMID: 34412829.Published on 8/29/2021
Duly K, Farraye FA, Bhat S. COVID-19 vaccine use in immunocompromised patients: A commentary on evidence and recommendations. Am J Health Syst Pharm. 2021 Aug 29. PMID: 34455440.Published on 8/18/2021
Shen B, Kochhar GS, Kariv R, Liu X, Navaneethan U, Rubin DT, Cross RK, Sugita A, D'Hoore A, Schairer J, Farraye FA, Kiran RP, Fleshner P, Rosh J, Shah SA, Chang S, Scherl E, Pardi DS, Schwartz DA, Kotze PG, Bruining DH, Kane SV, Philpott J, Abraham B, Segal J, Sedano R, Kayal M, Bentley-Hibbert S, Tarabar D, El-Hachem S, Sehgal P, McCormick JT, Picoraro JA, Silverberg MS, Bernstein CN, Sandborn WJ, Vermeire S. Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch Consortium. Lancet Gastroenterol Hepatol. 2021 10; 6(10):826-849. PMID: 34416186.Published on 8/1/2021
Hashash JG, Francis FF, Farraye FA. Diagnosis and Management of Immune Checkpoint Inhibitor Colitis. Gastroenterol Hepatol (N Y). 2021 Aug; 17(8):358-366. PMID: 34602898.Published on 7/27/2021
Squire JD, Gonzalez-Estrada A, Caldera F, Farraye FA. COVID-19 Vaccination in Patients With Inflammatory Bowel Disease and History of Reaction to Injectable Therapies. Inflamm Bowel Dis. 2021 07 27; 27(8):1358-1360. PMID: 33999204.Published on 7/27/2021
Bhat S, Caldera F, Farraye FA. Barriers to Administering Vaccines in Inflammatory Bowel Disease Centers. Inflamm Bowel Dis. 2021 07 27; 27(8):1356-1357. PMID: 33704465.Published on 7/20/2021
Moktan VP, Koop AH, Olson MT, Lewis MD, Gomez V, Farraye FA. An Unusual Cause of Large Bowel Obstruction in a Patient With Ulcerative Colitis. ACG Case Rep J. 2021 Jul; 8(7):e00638. PMID: 34307716.